ID: ALA5172121

Max Phase: Preclinical

Molecular Formula: C23H25N7O3

Molecular Weight: 447.50

Associated Items:

Representations

Canonical SMILES:  CCNC(=O)c1cncc(-c2cnn3cc(-c4cnn(CC)c4)c(O[C@H]4CCOC4)nc23)c1

Standard InChI:  InChI=1S/C23H25N7O3/c1-3-25-22(31)16-7-15(8-24-9-16)19-11-27-30-13-20(17-10-26-29(4-2)12-17)23(28-21(19)30)33-18-5-6-32-14-18/h7-13,18H,3-6,14H2,1-2H3,(H,25,31)/t18-/m0/s1

Standard InChI Key:  CCVQDAVSKDENJO-SFHVURJKSA-N

Associated Targets(Human)

FGFR3 Tclin Fibroblast growth factor receptor 3 (7811 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FGFR1 Tclin Fibroblast growth factor receptor 1 (9149 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP3A4 Tclin Cytochrome P450 3A4 (53859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Fgfr3 Fibroblast growth factor receptor 3 (21 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 447.50Molecular Weight (Monoisotopic): 447.2019AlogP: 2.59#Rotatable Bonds: 7
Polar Surface Area: 108.46Molecular Species: NEUTRALHBA: 9HBD: 1
#RO5 Violations: 0HBA (Lipinski): 10HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 13.90CX Basic pKa: 2.94CX LogP: 1.28CX LogD: 1.28
Aromatic Rings: 4Heavy Atoms: 33QED Weighted: 0.46Np Likeness Score: -1.46

References

1. Shvartsbart A, Roach JJ, Witten MR, Koblish H, Harris JJ, Covington M, Hess R, Lin L, Frascella M, Truong L, Leffet L, Conlen P, Beshad E, Klabe R, Katiyar K, Kaldon L, Young-Sciame R, He X, Petusky S, Chen KJ, Horsey A, Lei HT, Epling LB, Deller MC, Vechorkin O, Yao W..  (2022)  Discovery of Potent and Selective Inhibitors of Wild-Type and Gatekeeper Mutant Fibroblast Growth Factor Receptor (FGFR) 2/3.,  65  (22.0): [PMID:36356320] [10.1021/acs.jmedchem.2c01366]

Source